Testing Medication Injections for Lung Fluid Infections
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether injecting two medications (tPA and DNase) through a chest tube helps treat serious lung infections with fluid buildup. The goal is to see if this approach reduces the need for surgery and helps patients recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a serious lung infection with fluid around the lungs that requires a chest tube
- You have not received any medications injected into your chest cavity through a current chest tube before joining this trial
- You are not currently taking blood thinners (anticoagulation medications)
- You are able to give your own consent or have a designated family member or medical decision maker who can consent for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a once-daily enzyme treatment given through a chest tube to clear infected fluid from around the lungs. It may help people with complicated pneumonia or empyema who still have fluid buildup after initial drainage.
This study tests whether regularly flushing the chest tube with a small amount of liquid helps prevent blockages in people who have a severe lung infection that spreads to the chest cavity. If you need a chest tube for this type of infection, you may be able to join.
This trial tests a new device to wash out fluid that stays in the chest after a chest tube is placed. It might help people who cannot receive standard medication to break up this fluid within the first day after their chest tube is inserted.
This trial tests if adding a simple saltwater rinse to standard chest tube drainage helps clear stubborn lung infections. It might be an option if you have an infected fluid pocket in your chest that isn't draining well.
This trial tests two combinations of medicines for people with infected fluid around the lung that isn't draining well through a chest tube. The goal is to see which combination works better to clear the infection and improve recovery.
This study tests whether a lower dose of alteplase (a clot-busting medicine) given into the chest can improve healing of infected pleural fluid when drainage is incomplete. It may help reduce dosing-related side effects while still helping clear the infection-related fluid.
Hear when a new Empyema, Pleural trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.